Announced Mon, 17 Aug · 14:25 IST
Non-promoter group acquires 58% stake in Parmax Pharma via off-market SPA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹117.75
prior close
₹120.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.3+11.4—+13.6———
Up moveDown movePending
AI summary
A group of 12 non-promoter entities led by Dhiren Shah and Sunil Shah acquired 11,52,450 equity shares (30.81 percent of capital) of Parmax Pharma via off-market Share Purchase Agreement dated June 8, 2026. Combined holding rose from 27.20 percent to 58.01 percent, crossing the 50 percent majority threshold. Acquisition completed on August 13, 2026. Total share capital is 37,41,300 shares of Rs 10 face value.
Likely market impact
Possible change of control as non-promoters now hold majority. Watch for SEBI open offer exemption or mandatory tender. Signals strategic shift.